Please assess the completion status of the following clinical trial:

Trial Title: Study of the Sars-Cov2 Neuroinvasiveness - COVID19

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* COVID-19 patients requiring an external ventricular drain, a decompressive craniectomy or an intracranial hematoma surgery~Exclusion Criteria:~* Pregnant or lactating women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Neurological biological samples (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).